HR 586
Vietnam Veterans Liver Fluke Cancer Study Act
Summary
Vietnam Veterans Liver Fluke Cancer Study Act This bill requires the Department of Veterans Affairs (VA) to conduct an epidemiological study and report on the prevalence of cholangiocarcinoma (bile duct cancer) in veterans who served in the Vietnam theater of operations during the Vietnam era. The study must identify the rate of incidence of cholangiocarcinoma in such veterans and in U.S. residents. The bill also requires the VA to track and report on the prevalence of cholangiocarcinoma using the Veterans Affairs Central Cancer Registry. Additionally, the VA must periodically submit follow-up reports to Congress regarding the epidemiological study and information collected from the cancer registry regarding the prevalence of bile duct cancer.
Bill status
- Status
- Passed House
- Sponsor
- Rep. Nick LaLota [R-NY-1]
- Cosponsors
- 8
- Policy area
- Armed Forces and National Security
- Introduced
- 2025-01-21
- Latest action
- 2025-04-08: Received in the Senate and Read twice and referred to the Committee on Veterans' Affairs.
Committee referrals
Recent actions
- 2025-04-08: Received in the Senate and Read twice and referred to the Committee on Veterans' Affairs.
- 2025-04-07: Motion to reconsider laid on the table Agreed to without objection.
- 2025-04-07: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 411 - 0 (Roll no. 89). (text: CR H1435-1436)
- 2025-04-07: Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 411 - 0 (Roll no. 89). (text: CR H1435-1436: 1)
- 2025-04-07: Considered as unfinished business. (consideration: CR H1441-1442)